Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ARS Pharmaceuticals, Inc. - Common Stock (NQ: SPRY ) 15.36 +0.16 (+1.05%) Streaming Delayed Price Updated: 3:59 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ARS Pharmaceuticals, Inc. - Common Stock < Previous 1 2 3 4 Next > ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates August 10, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire Analyst Expectations for ARS Pharmaceuticals's Future June 21, 2023 Via Benzinga ARS Pharmaceuticals Announces PDUFA Date Extension for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis June 20, 2023 Additional Time Needed for Labeling and Post-Marketing Requirements Discussions; PDUFA Date Set for September 19, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results May 15, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire FDA Issues Some Concerns Regarding ARS Pharma's Investigational Allergy Treatment May 09, 2023 The FDA released Via Benzinga ONEOK, PacWest Bancorp And Other Big Stocks Moving Lower In Monday's Pre-Market Session May 15, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Nasdaq Down 100 Points; Crude Oil Drops Over 1% May 12, 2023 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Friday. The Dow traded down 0.43% to 33,164.71 while the NASDAQ fell 0.82% to 12,227.60. The... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 12, 2023 Via Benzinga Dow Turns Lower; Getaround Shares Jump May 12, 2023 U.S. stocks traded lower midway through trading, with the Dow Jones turning lower on Friday. The Dow traded down 0.25% to 33,226.13 while the NASDAQ fell 0.45% to 12,271.22. The S&P 500, also fell,... Via Benzinga Arlo Technologies, Array Technologies, AirSculpt Technologies And Other Big Stocks Moving Higher On Friday May 12, 2023 U.S. stocks traded slightly lower, with the Dow Jones dropping around 15 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 12, 2023 Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,... Via Benzinga Why ARS Pharmaceuticals Stock Is Soaring Today May 12, 2023 The FDA's Pulmonary-Allergy Drug Advisory Committee voted 16-6 in favor of ARS Pharmaceuticals Inc's (NASDAQ: SPRY) neffy in treating severe allergic reactions for adults (and 16-5 for Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 12, 2023 Via Benzinga INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm May 12, 2023 From The Schall Law Firm Via Business Wire FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis May 11, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm May 10, 2023 From The Schall Law Firm Via Business Wire Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 10, 2023 Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. Via Benzinga Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of ARS Pharmaceuticals, Inc. (SPRY) Investigation May 10, 2023 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire ARS Pharmaceuticals Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on neffy® for the Treatment of Type I Allergic Reactions Including Anaphylaxis May 09, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Announces FDA Advisory Committee for neffy® for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis March 28, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 27, 2023 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. Via Benzinga BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday March 27, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results March 23, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors February 23, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis February 22, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023 February 09, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023 January 31, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023 January 04, 2023 Via Benzinga Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session December 16, 2022 Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. Via Benzinga Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session December 13, 2022 Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
